Professor Dr. Supot Hannongbua
- Room 1115 Mahamakut Building, Department of Chemistry, Faculty of Science Chulalongkorn University Phayathai Road, Patumwan Bangkok 10330, THAILAND
- 02-2187707
Education
- [1992] Ph.D., Innsbruck University, Austria
- [1989] M.Sc., Mahidol University
- [1987] B.Sc., Khonkaen University
Work Experiences
- Dean, Faculty of Science, Chulalongkorn University
- President, the Science Society of Thailand under the Patronage of his Majesty the King
- Vice President, Science Council of Asia (SCA)
- Vice President, Thai Academy of Science and Technology Foundation (TAST)
- Executive Board, The Institute for the Promotion of Teaching Science and Technology (IPST)
- Executive Board, National Metal and Materials Technology Center (MTEC), National Science and Technology Agency (NSTDA)
- Executive Board, National Science Museum (NSM)
- Vice chairman, Council of Science Deans of Thailand
Current Research Topics
- Structure Based Drug Screening and Design; Molecular Design and Molecular Architecture of Nanomaterials.
Scholarship and Awards
- Most Cited TRF-Research Publication Award, TRF
- The TRF Senior Scholar, The Thailand Research Fund (TRF)
- Outstanding Scientist, Foundation for the Promotion of Science and Technology under the Patronage of his Majesty the King
- The National Award for the Distinguished Researcher, National Research Council of Thailand (NRCT)
- TWAS Prize for Young Scientists in Thailand, Third World Academy of Science
- Young Scientist Award, Foundation for the Promotion of Science and Technology under the Patronage of his Majesty the King
- CST Distnguished Chemist Award 2014 From Chemical Society of Thailand under the Patronage of Her Royal Highness Princess Chulabhorn Mahidol
Publications
•FMO-guided design of darunavir analogs as HIV-1 protease inhibitors. Scientific Reports.
2024. Cited 3
•In vitro and in silico studies of the inclusion complexation of 8-bromobaicalein with β-cyclodextrins. Journal of Molecular Graphics and Modelling. 2024. Cited 0
•Alpha and gamma mangostins inhibit wild-type B SARS-CoV-2 more effectively than the SARS-CoV-2 variants and the major target is unlikely the 3C-like protease. Heliyon. 2024. Cited 0
•Machine learning-guided design of potent darunavir analogs targeting HIV-1 proteases: A computational approach for antiretroviral drug discovery. Journal of Computational Chemistry. 2024. Cited 2
•N501Y mutation in SARS-CoV-2 spike RBD protein enhances its binding to ACE2 receptor. Asia-Pacific Journal of Science and Technology. 2024. Cited 0
Full list
•In vitro and in silico studies of the inclusion complexation of 8-bromobaicalein with β-cyclodextrins. Journal of Molecular Graphics and Modelling. 2024. Cited 0
•Alpha and gamma mangostins inhibit wild-type B SARS-CoV-2 more effectively than the SARS-CoV-2 variants and the major target is unlikely the 3C-like protease. Heliyon. 2024. Cited 0
•Machine learning-guided design of potent darunavir analogs targeting HIV-1 proteases: A computational approach for antiretroviral drug discovery. Journal of Computational Chemistry. 2024. Cited 2
•N501Y mutation in SARS-CoV-2 spike RBD protein enhances its binding to ACE2 receptor. Asia-Pacific Journal of Science and Technology. 2024. Cited 0
Full list